Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells
dc.contributor.author | Salkin, Hasan | |
dc.contributor.author | Satir-Basaran, Guzide | |
dc.contributor.author | Korkmaz, Seyda | |
dc.contributor.author | Gonen, Zeynep Burcin | |
dc.contributor.author | Basaran, Kemal Erdem | |
dc.date.accessioned | 2024-03-13T10:30:56Z | |
dc.date.available | 2024-03-13T10:30:56Z | |
dc.date.issued | 2023 | |
dc.department | İstanbul Beykent Üniversitesi | en_US |
dc.description.abstract | Objective: (s): We aimed to investigate the effects of mesenchymal stem cell secretome and methysergide com-bination on 5-hydroxytryptamine 2A, (5-HT2AR), 5-hydroxytryptamine 7 (5-HT7R), adenosine 2A (A2AR) re-ceptors and CD73 on neuroblastoma cell line and how they affect biological characteristics. Methysergide was used as a serotonin antagonist on the neuroblastoma cells.Materials and methods: Human dental pulp-derived stem cells (hDPSCs) used to obtain conditioned medium (CM). Methysergide drug was prepared in CM and applied to neuroblastoma cells. Analysis of 5-HT7R, 5-HT2AR, A2AR and CD73 expressions was performed by western blot and immunofluorescence staining. Total apoptosis, mitochondrial membrane depolarization, Ki-67 proliferation test, viability analysis, DNA damage and cell cycle analysis were performed in accordance with the product procedure by using biological activity test kits.Results: Our results showed that neuroblastoma cancer cells are normally on the Gs signaling axis via the sero-tonin 7 receptor and the adenosine 2A receptor. CM and Methysergide inhibited the 5-HT7 and A2A receptor levels in neuroblastoma cells. We found that CM and methysergide formed crosstalk inhibition between 5-HT2AR, 5-HT7R, A2AR and CD73. CM and Methysergide increased the total apoptosis in neuroblastoma cells and induced the mitochondrial membrane depolarization. CM and Methysergide induced the DNA damage and arrested in G0/G1 phase of cell cycle of the neuroblastoma cells.Conclusion: These findings suggest that the combination of CM and methysergite may exert a therapeutic effect on neuroblastoma cancer cells, and future in vivo studies may be important in area of neuroblastoma research to support the findings. | en_US |
dc.identifier.doi | 10.1016/j.brainres.2023.148354 | |
dc.identifier.issn | 0006-8993 | |
dc.identifier.issn | 1872-6240 | |
dc.identifier.pmid | 36997105 | en_US |
dc.identifier.scopus | 2-s2.0-85151447049 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.brainres.2023.148354 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12662/3617 | |
dc.identifier.volume | 1808 | en_US |
dc.identifier.wos | WOS:000972407500001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Brain Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Methysergide | en_US |
dc.subject | Serotonin receptors | en_US |
dc.subject | A2A receptor | en_US |
dc.subject | CD73 | en_US |
dc.subject | Neuroblastoma | en_US |
dc.subject | Mesenchymal stem cell | en_US |
dc.title | Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells | en_US |
dc.type | Article | en_US |